Number of lymph nodes identified at axillary dissection: Effect of neoadjuvant chemotherapy and other factors

Judy C Boughey, John H. Donohue, James W Jakub, Christine M. Lohse, Amy C Degnim

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

BACKGROUND: Several reports have shown a significantly lower number of axillary lymph nodes (AxLNs) found at axillary lymph node dissection (ALND) after neoadjuvant chemotherapy. The objective of the current study was to investigate the factors affecting the number of AxLNs identified at ALND. METHODS: Medical records of patients seen at the study institution, a tertiary center, from 2004 to 2007 who underwent ALND for breast cancer were reviewed. RESULTS: Among the 698 patients who met study criteria, the mean number of AxLNs resected was 20.4. There were 649 (93%) patients with at least 10 AxLNs recovered. Seventy-one (10%) patients received neoadjuvant chemotherapy and 627 (90%) underwent surgical resection first. The mean number of AxLNs in the patients treated with neoadjuvant chemotherapy was 21.9 (range, 4-56 AxLNs) compared with 20.2 (range, 5-65 AxLNs) in the group treated with surgical resection first (P=13). The number of patients with <10 AxLNs found at ALND was 44 of 627 (7.0%) in the surgical resection first group and 5 of 71 (7.0%) in the neoadjuvant chemotherapy group (P=1.0). The mean number of AxLNs was higher in the 599 (86%) ALNDs performed at the study center compared with the 99 cases from outside institutions (21.2 vs 15.2 AxLNs; P <.001). Among the cases performed at the study institution, 367 (61%) were performed by surgeons with oncologic training and 232 (39%) were not. Surgical oncologists recovered an average of 23 AxLNs, which was significantly higher than the 18.4 resected by the remaining surgeons (P <.001). CONCLUSIONS: The number of AxLNs recovered at ALND does not appear to be affected by neoadjuvant chemotherapy. Surgeons with oncologic training appear to retrieve more AxLNs.

Original languageEnglish (US)
Pages (from-to)3322-3329
Number of pages8
JournalCancer
Volume116
Issue number14
DOIs
StatePublished - Jul 15 2010

Fingerprint

Dissection
Lymph Nodes
Drug Therapy
Lymph Node Excision
Medical Records
Breast Neoplasms

Keywords

  • Axillary lymph node dissection
  • Axillary lymph nodes
  • Neoadjuvant chemotherapy
  • Surgical training

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Number of lymph nodes identified at axillary dissection : Effect of neoadjuvant chemotherapy and other factors. / Boughey, Judy C; Donohue, John H.; Jakub, James W; Lohse, Christine M.; Degnim, Amy C.

In: Cancer, Vol. 116, No. 14, 15.07.2010, p. 3322-3329.

Research output: Contribution to journalArticle

@article{b1bbd52111e243c580bf4b6d55299823,
title = "Number of lymph nodes identified at axillary dissection: Effect of neoadjuvant chemotherapy and other factors",
abstract = "BACKGROUND: Several reports have shown a significantly lower number of axillary lymph nodes (AxLNs) found at axillary lymph node dissection (ALND) after neoadjuvant chemotherapy. The objective of the current study was to investigate the factors affecting the number of AxLNs identified at ALND. METHODS: Medical records of patients seen at the study institution, a tertiary center, from 2004 to 2007 who underwent ALND for breast cancer were reviewed. RESULTS: Among the 698 patients who met study criteria, the mean number of AxLNs resected was 20.4. There were 649 (93{\%}) patients with at least 10 AxLNs recovered. Seventy-one (10{\%}) patients received neoadjuvant chemotherapy and 627 (90{\%}) underwent surgical resection first. The mean number of AxLNs in the patients treated with neoadjuvant chemotherapy was 21.9 (range, 4-56 AxLNs) compared with 20.2 (range, 5-65 AxLNs) in the group treated with surgical resection first (P=13). The number of patients with <10 AxLNs found at ALND was 44 of 627 (7.0{\%}) in the surgical resection first group and 5 of 71 (7.0{\%}) in the neoadjuvant chemotherapy group (P=1.0). The mean number of AxLNs was higher in the 599 (86{\%}) ALNDs performed at the study center compared with the 99 cases from outside institutions (21.2 vs 15.2 AxLNs; P <.001). Among the cases performed at the study institution, 367 (61{\%}) were performed by surgeons with oncologic training and 232 (39{\%}) were not. Surgical oncologists recovered an average of 23 AxLNs, which was significantly higher than the 18.4 resected by the remaining surgeons (P <.001). CONCLUSIONS: The number of AxLNs recovered at ALND does not appear to be affected by neoadjuvant chemotherapy. Surgeons with oncologic training appear to retrieve more AxLNs.",
keywords = "Axillary lymph node dissection, Axillary lymph nodes, Neoadjuvant chemotherapy, Surgical training",
author = "Boughey, {Judy C} and Donohue, {John H.} and Jakub, {James W} and Lohse, {Christine M.} and Degnim, {Amy C}",
year = "2010",
month = "7",
day = "15",
doi = "10.1002/cncr.25207",
language = "English (US)",
volume = "116",
pages = "3322--3329",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "14",

}

TY - JOUR

T1 - Number of lymph nodes identified at axillary dissection

T2 - Effect of neoadjuvant chemotherapy and other factors

AU - Boughey, Judy C

AU - Donohue, John H.

AU - Jakub, James W

AU - Lohse, Christine M.

AU - Degnim, Amy C

PY - 2010/7/15

Y1 - 2010/7/15

N2 - BACKGROUND: Several reports have shown a significantly lower number of axillary lymph nodes (AxLNs) found at axillary lymph node dissection (ALND) after neoadjuvant chemotherapy. The objective of the current study was to investigate the factors affecting the number of AxLNs identified at ALND. METHODS: Medical records of patients seen at the study institution, a tertiary center, from 2004 to 2007 who underwent ALND for breast cancer were reviewed. RESULTS: Among the 698 patients who met study criteria, the mean number of AxLNs resected was 20.4. There were 649 (93%) patients with at least 10 AxLNs recovered. Seventy-one (10%) patients received neoadjuvant chemotherapy and 627 (90%) underwent surgical resection first. The mean number of AxLNs in the patients treated with neoadjuvant chemotherapy was 21.9 (range, 4-56 AxLNs) compared with 20.2 (range, 5-65 AxLNs) in the group treated with surgical resection first (P=13). The number of patients with <10 AxLNs found at ALND was 44 of 627 (7.0%) in the surgical resection first group and 5 of 71 (7.0%) in the neoadjuvant chemotherapy group (P=1.0). The mean number of AxLNs was higher in the 599 (86%) ALNDs performed at the study center compared with the 99 cases from outside institutions (21.2 vs 15.2 AxLNs; P <.001). Among the cases performed at the study institution, 367 (61%) were performed by surgeons with oncologic training and 232 (39%) were not. Surgical oncologists recovered an average of 23 AxLNs, which was significantly higher than the 18.4 resected by the remaining surgeons (P <.001). CONCLUSIONS: The number of AxLNs recovered at ALND does not appear to be affected by neoadjuvant chemotherapy. Surgeons with oncologic training appear to retrieve more AxLNs.

AB - BACKGROUND: Several reports have shown a significantly lower number of axillary lymph nodes (AxLNs) found at axillary lymph node dissection (ALND) after neoadjuvant chemotherapy. The objective of the current study was to investigate the factors affecting the number of AxLNs identified at ALND. METHODS: Medical records of patients seen at the study institution, a tertiary center, from 2004 to 2007 who underwent ALND for breast cancer were reviewed. RESULTS: Among the 698 patients who met study criteria, the mean number of AxLNs resected was 20.4. There were 649 (93%) patients with at least 10 AxLNs recovered. Seventy-one (10%) patients received neoadjuvant chemotherapy and 627 (90%) underwent surgical resection first. The mean number of AxLNs in the patients treated with neoadjuvant chemotherapy was 21.9 (range, 4-56 AxLNs) compared with 20.2 (range, 5-65 AxLNs) in the group treated with surgical resection first (P=13). The number of patients with <10 AxLNs found at ALND was 44 of 627 (7.0%) in the surgical resection first group and 5 of 71 (7.0%) in the neoadjuvant chemotherapy group (P=1.0). The mean number of AxLNs was higher in the 599 (86%) ALNDs performed at the study center compared with the 99 cases from outside institutions (21.2 vs 15.2 AxLNs; P <.001). Among the cases performed at the study institution, 367 (61%) were performed by surgeons with oncologic training and 232 (39%) were not. Surgical oncologists recovered an average of 23 AxLNs, which was significantly higher than the 18.4 resected by the remaining surgeons (P <.001). CONCLUSIONS: The number of AxLNs recovered at ALND does not appear to be affected by neoadjuvant chemotherapy. Surgeons with oncologic training appear to retrieve more AxLNs.

KW - Axillary lymph node dissection

KW - Axillary lymph nodes

KW - Neoadjuvant chemotherapy

KW - Surgical training

UR - http://www.scopus.com/inward/record.url?scp=77954888714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954888714&partnerID=8YFLogxK

U2 - 10.1002/cncr.25207

DO - 10.1002/cncr.25207

M3 - Article

C2 - 20564124

AN - SCOPUS:77954888714

VL - 116

SP - 3322

EP - 3329

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 14

ER -